ArticleMedComm2026

EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer.

Ruoxi Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.